Dementia study

Principal Investigators: 
Prof. Rayaz Malik (Professor of Medicine & Senior Consultant, WCM-Q & HMC)
Dr. Hanadi Al Hamad (Chairman of Geriatric Dept. & Senior Consultant, WCM-Q & HMC) 

Mr. Georgios Ponirakis (Clinical Researcher)
Dr. Adnan Khan (Post Doctoral Associate in Medicine)
Dr. Anoop Sankaranarayanan (Consultant)
Dr. Marwan Ramadan (Consultant)
Dr. Shafi Khan (Consultant)
Dr. Essa AlSulaiti (Consultant)
Dr. Ahmed Elsotouhy (Radiologist)
Dr. Mani Chandran (Consultant)
Ms. Priya Vitthal Gawhale (Nurse)
Ms. Rhia Tosino (Nurse)
Dr. Maryam Alobaidi (Consultant)
Mr. Noushad Thodi (MRI In-charge)
Dr. Susan Osman (Consultant)
Dr. Navas Nadukkandiyil (Consultant)
Ms. Marwa Elorrabi (Nurse)
Dr. Ioannis Petropoulos (Post Doctoral Associate in Medicine)
Prof. Ashfaq Shuaib (Director of Neuroscience Institute) 

Early identification of dementia is important to ensure patients are offered treatment early in order to achieve a better quality of life and more independence. The objectives of this study are as follows:

    To prospectively use CCM in patients attending the memory clinic to:
  1. Study its clinical potential as a dementia biomarker.
  2. Characterise corneal nerve/endothelial changes seen in patients with cognitive impairment and/or dementia.
  3. Identify corneal/endothelial changes that will assist in identifying or differentiating patients with different types of dementia (e.g. Alzheimer's versus Vascular) and different severity (mild versus moderate versus severe) of cognitive impairment and/or dementia.